Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals ARWR
$ 18.49 1.15%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Arrowhead Pharmaceuticals EV/EBITDA Ratio 2011-2024 | ARWR

Annual EV/EBITDA Ratio Arrowhead Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-30.8 -64.5 53.9 -19.8 -7.66 -3.6 -2.29 -3.69 -6.91 -1.12 -3.17

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
53.9 -64.5 -8.15